Plunkett Research Online: Inovio Pharmaceuticals Inc

INOVIO PHARMACEUTICALS INC (INO:NAS) Company Profile, Corporate Revenues, Growth, Market Size, Analysis, Business Forecasts, Market Share, Metrics, SWOT

Inovio Biomedical Corporation is a Delaware corporation, organized in 2001. The Company is engaged in the development of preventive and therapeutic DNA vaccines for cancers and infectious diseases using its novel electroporation DNA delivery technology. Electroporation uses brief, controlled elect.....



Inovio Pharmaceuticals Inc
Ticker: INO
Exchange: NAS
Parent Company:
Year Established:
Employees:
Fiscal Year Ends in

Phone: 267 440-4200
Fax: 267 440-4242
Address: 660 West Germantown Pike
Suite 110
Plymouth Meeting, PA 19462 United States

Types Of Business
Industry Ranks

Industry NAICS code:

Pharmaceuticals
Cancer Vaccines
ContactsDescription
J. KimCEO/Director/President
Peter KiesCFO/Chief Accounting Officer
See More
Inovio Biomedical Corporation is a Delaware corporation, organized in 2001. The Company is engaged in the development of preventive and therapeutic DNA vaccines for cancers and infectious diseases using its novel electroporation DNA delivery technology. Electroporation uses brief, controlled elect.....See More See More

Auditor: Ernst & Young LLP
Legal Advisor:
$USD, In whole numbers,
except marked * or %
201620152014201320122011
Financials
    Revenue
    Cost of Revenue
    Gross Margin %
    R&D Expense
    Operating Income
    Operating Margin %
    SGA Expense
    Net Income
    Earnings Per Share
    Dividends
    Book Value Per Share
    Operating Cash Flow
    Capital Expenditure
    Free Cash Flow
Profitability
    EBITDA
    Return on Assets %
    Return on Equity %
    Net Margin %
    Assets Turnover
    Financial Leverage
Brands, Divisions and AffiliatesTop Salaries
NameTitleSalary (US$)Bonus (US$)
Other ThoughtsCorporate Culture

Apparent Female Officers or Directors: